Trafermin is a recombinant human fibroblast growth factor-2 (rhFGF-2) protein. It plays a crucial role in tissue regeneration and wound healing. Trafermin is used in the biomedical industry to promote the healing of chronic skin ulcers, such as pressure ulcers and diabetic foot ulcers. It aids in the proliferation of cells and stimulates blood vessel formation, resulting in accelerated wound closure and improved tissue repair.
CAT# | R1989 |
CAS | 131094-16-1 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Iron chelating agent is a new type of iron-removing treatment based on the combination of directional and in viv ...
Orexin A (OXA) and orexin B (OXB) are hypothalamic neuropeptides discovered in 1998, which bind to two G-protein ...
Anisomycin, also known by its trade name flagecidin, is a bacterial pyrrolidine antibiotic mostly isolated from ...
C 21 is a kind of selective protein arginine methyltransferase 1 (PRMT1) inhibitor (IC50 = 1.8 μM). And it exhib ...
Pramlintide is a synthetic analogue of pancreatic amyloid polypeptide. Pancreatic amyloid polypeptide is a polyp ...